knowledge -WSS

knowledge

author：fashion 2025-09-30 11:58:01 - browse：81423

A young boy died in a trial for Pfizer’s experimental gene therapy for Duchenne muscular dystrophy, the company told patient advocates Tuesday.

The boy was enrolled in Daylight, a trial studying the treatment in boys aged 2 or 3. The boy had received the therapy early last year, Pfizer told the advocates in a note posted online by Parent Project Muscular Dystrophy.

Pfizer said the boy died of cardiac arrest, but that it was still working to understand what happened and the exact cause.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Reports of telehealth's death have been greatly exaggerated

WSS

Addressing health care workers' trauma can help fight burnout

Addressing health care workers' trauma can help fight burnout

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

Chemotherapy before breast cancer surgery might fuel metastasis

Bird flu surveillance in wastewater gets boost from consortium

HHS's proposed rule does nothing to address the climate crisis

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Study finds gene variants tied to breast cancer risk in Black women

Trump demands the U.S. pay no more for drugs than other countries … again

Brain technologies pose threats that are all too real, experts warn

Medical leaders decry Supreme Court decision on affirmative action

Eyeing GLP

Tori Bowie and the unacceptable rates of Black maternal death

ASCO eve: Let’s set the table for this year's meeting

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Is it ever OK for doctors to lie to their patients?

focus

Empower primary care with adequate payments and technology

Black vets could get higher VA benefits if race not used in lung test

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Warren pushes Witty on UnitedHealth's control over physicians

Eyeing GLP

Addressing health care workers' trauma can help fight burnout

focus

leisure time

hotspot

explore